The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-2-[(1H-pyrrolo[2,3-b]pyridin-3-yl)methylene]-6-hydroxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one ID: ALA4102902
PubChem CID: 86681992
Max Phase: Preclinical
Molecular Formula: C21H20N4O3
Molecular Weight: 376.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1/C(=C/c2c[nH]c3ncccc23)Oc2c1ccc(O)c2CN1CCNCC1
Standard InChI: InChI=1S/C21H20N4O3/c26-17-4-3-15-19(27)18(10-13-11-24-21-14(13)2-1-5-23-21)28-20(15)16(17)12-25-8-6-22-7-9-25/h1-5,10-11,22,26H,6-9,12H2,(H,23,24)/b18-10-
Standard InChI Key: JKEWQEZHKJUJJG-ZDLGFXPLSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
24.3946 -4.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3935 -5.0747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1015 -5.4836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0997 -3.8463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0973 -3.0291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3884 -2.6226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3840 -1.8019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6792 -1.3955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9703 -1.8028 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9707 -2.6209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6801 -3.0318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8084 -4.2515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8132 -5.0747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5976 -5.3245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0776 -4.6557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5898 -3.9926 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8546 -6.1002 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8947 -4.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2992 -3.9408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1082 -3.8517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2734 -3.0514 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.9593 -3.1974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5618 -2.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3884 -1.8567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6131 -1.6095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0110 -2.1619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1875 -2.9532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6868 -3.8467 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 13 2 0
12 4 2 0
4 1 1 0
4 5 1 0
5 6 1 0
6 7 1 0
6 11 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
14 17 2 0
15 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 23 1 0
22 19 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
1 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 376.42Molecular Weight (Monoisotopic): 376.1535AlogP: 2.29#Rotatable Bonds: 3Polar Surface Area: 90.48Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.86CX Basic pKa: 9.12CX LogP: 0.45CX LogD: 0.39Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.61Np Likeness Score: -0.69
References 1. Nakano H, Hasegawa T, Kojima H, Okabe T, Nagano T.. (2017) Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket., 8 (5): [PMID:28523101 ] [10.1021/acsmedchemlett.6b00518 ]